Aarvik Therapeutics, Inc. — Form D
Aarvik Therapeutics, Inc. of Hayward, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-11. The offering totals $15.0M, of which $1.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-12-11
- Form: D
- Accession: 0001881431-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $15.0M
- Amount sold: $1.2M
- Remaining: $13.8M
- Investors: 5
- Date of first sale: 2024-11-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-531747
Issuer
- Name: Aarvik Therapeutics, Inc.
- CIK: 0001881431
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 31363 Medallion Drive, Hayward, CA, 94544
- Phone: 408 741-1889
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Anula Jayasuriya | Director | San Francisco, CA |
| Jagath Reddy Junutula | Director | Hayward, CA |
| Ram Kalakoti Reddy | Director | Hayward, CA |
| Richard Scheller | Director | Hayward, CA |
| Sachdev Sidhu | Director | Hayward, CA |
| Jagath Reddy Junutula | Executive Officer | Hayward, CA |
Other filings by this issuer (1)
More